Cardiac hypertrophy and cardiomyopathy are critical events in the onset of heart failure. The identification of specific pathways which activate defined contractile, electrophysiological, myocyte growth, and cardiac cell survival responses of the hypertrophied and failing heart is critical for development of biologically targeted therapy. Recent studies have implicated a pivotal role for biomechanical and hormonal signals from the extracellular matrix, cardiac cytokine and G protein coupled receptors, cardiac cytoskeletal pathways, and downstream intracellular kinases. Accordingly, the central objective of the present project is to identify intersecting molecular pathways that trigger important features of cardiac hypertrophy, cardiomyopathy, and the transition of heart failure. The program will capitalize on germline and somatic gene modifications in unique genetically engineered model systems, incorporating a spectrum of physiological assays for specific functional phenotypes in living animals, intact muscle, and single cells. The program will explore the role of cytoskeletal signaling pathways that emanate from focal adhesion complexes, a newly described MLP-telethonin complex, and a novel LIM domain protein (FHLI/SLIM1). Mechanistic links between these signaling pathways for hypertrophy and cardiomyopathy and myocyte survival pathways will be examined in relation to a new stress-inducible negative regulator of gp130 cytokines (SOCS 3). Biomechanical stretch and hormonal induced pathways for hypertrophy will be directly examined in both in vitro and in vivo systems, with a focus on integrins, novel G protein coupled receptors, and CAM kinase. The program integrates the independent expertise of the three project leaders in genetically engineered mouse models of human cardiac disease (K. Chien), the molecular pharmacology of cardiac signals for hypertrophy (J. Brown), and cardiovascular bioengineering technology and computational modeling of biomechanical stress responses during cardiac remodeling (A. McCulloch). The Program will integrate state-of-the-art technology via our Myocardial Cell Biology and Viral Vector Core A (K. Knowlton/S. Evans), Transgenic and Gene Targeted Mouse Core B (J. Chen/K. Chien), and Animal Physiology and In Vivo Gene Transfer Core C (J. Ross). The long history of collaboration amongst the Program investigators should lead to new therapeutic insights.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL046345-11
Application #
6522108
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Liang, Isabella Y
Project Start
1992-02-01
Project End
2007-07-31
Budget Start
2002-08-25
Budget End
2003-07-31
Support Year
11
Fiscal Year
2002
Total Cost
$1,995,340
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Dewan, Sukriti; McCabe, Kimberly J; Regnier, Michael et al. (2016) Molecular Effects of cTnC DCM Mutations on Calcium Sensitivity and Myofilament Activation-An Integrated Multiscale Modeling Study. J Phys Chem B 120:8264-75
Peter, Angela K; Bradford, William H; Dalton, Nancy D et al. (2016) Increased Echogenicity and Radiodense Foci on Echocardiogram and MicroCT in Murine Myocarditis. PLoS One 11:e0159971
Sheikh, Farah; Lyon, Robert C; Chen, Ju (2015) Functions of myosin light chain-2 (MYL2) in cardiac muscle and disease. Gene 569:14-20
Israeli-Rosenberg, Sharon; Chen, Chao; Li, Ruixia et al. (2015) Caveolin modulates integrin function and mechanical activation in the cardiomyocyte. FASEB J 29:374-84
Stroud, Matthew J; Banerjee, Indroneal; Veevers, Jennifer et al. (2014) Linker of nucleoskeleton and cytoskeleton complex proteins in cardiac structure, function, and disease. Circ Res 114:538-48
Zemljic-Harpf, Alice E; Godoy, Joseph C; Platoshyn, Oleksandr et al. (2014) Vinculin directly binds zonula occludens-1 and is essential for stabilizing connexin-43-containing gap junctions in cardiac myocytes. J Cell Sci 127:1104-16
Lyon, Robert C; Mezzano, Valeria; Wright, Adam T et al. (2014) Connexin defects underlie arrhythmogenic right ventricular cardiomyopathy in a novel mouse model. Hum Mol Genet 23:1134-50
Pfeiffer, E R; Wright, A T; Edwards, A G et al. (2014) Caveolae in ventricular myocytes are required for stretch-dependent conduction slowing. J Mol Cell Cardiol 76:265-74
Bang, Marie-Louise; Gu, Yusu; Dalton, Nancy D et al. (2014) The muscle ankyrin repeat proteins CARP, Ankrd2, and DARP are not essential for normal cardiac development and function at basal conditions and in response to pressure overload. PLoS One 9:e93638
Israeli-Rosenberg, Sharon; Manso, Ana Maria; Okada, Hideshi et al. (2014) Integrins and integrin-associated proteins in the cardiac myocyte. Circ Res 114:572-586

Showing the most recent 10 out of 144 publications